Hang Seng Index Rises 140 Points; Healthcare Stocks Lead Rally
SingTao · 2 SOURCESabout 3 hours ago2 MIN
Summary
The Hang Seng Index extended its winning streak to two consecutive sessions, rising 140 points or 0.57% to settle at 24,891 by midday Monday. The benchmark gauge fluctuated between gains of 175 points and a modest opening loss of 2 points before settling into positive territory, with trading turnover reaching approximately HK$108.5 billion. Healthcare-related stocks dominated the leaderboard, while major technology names provided broader market support.
Key Points
- Sino Biopharm (1177) surged 8.6% to HK$5.90, emerging as the top-performing blue chip, followed by CSPC (1093) up 7% and WuXi Biologics (2269) climbing 5.4%
- Xiaomi (1810) advanced 3.8% after CEO Lei Jun announced the upcoming launch of the Xiaomi 18 Pro series scheduled for Wednesday evening at 7pm
- Technology heavyweights Alibaba (9988) and Tencent (700) each gained 1.7%, while Lenovo (992) slumped 5.6% to HK$35.40, becoming the biggest drag on the index
- AI-related stocks weakened, with Zhipu AI (2513) falling 4.5% and MiniMax (100) declining 4.2%, though Zhipu responded to privacy concerns by open-sourcing its ZCode platform
- Impel Pharmaceuticals (7630) skyrocketed 42.1% to HK$18.52 following news of its Sepalna product achieving an international milestone and potential inclusion in the Stock Connect program
- New World Development (17) rose nearly 2% after the Shanghai Stock Exchange accepted its application to list Shanghai properties as a commercial real estate investment trust
- US-China leaders are scheduled to meet on Thursday, with President Trump personally greeting President Xi Jinping at the airport, a notably rare diplomatic gesture that has bolstered market sentiment
Why It Matters
The convergence of the healthcare sector rally and the upcoming US-China summit creates a pivotal moment for Hong Kong markets. Analysts suggest that positive outcomes from Thursday's talks could propel the Hang Seng Index toward the 25,000-25,300 range, though persistent concerns over US Treasury yields remaining above 5% may continue to cap upside potential .
The convergence of the healthcare sector rally and the upcoming US-China summit creates a pivotal moment for Hong Kong markets. Analysts suggest that positive outcomes from Thursday's talks could propel the Hang Seng Index toward the 25,000-25,300 range, though persistent concerns over US Treasury yields remaining above 5% may continue to cap upside potential .